Close menu




January 26th, 2022 | 11:01 CET

Bayer, MAS Gold, BASF: 5.7% dividend? These intrinsic values score now!

  • Gold
Photo credits: pixabay.com

According to capital market strategist Ulrich Stephan from Deutsche Bank, substantial stocks could have an advantage in the upcoming market phase. The reason: When interest rates rise, the refinancing costs for growth companies increase significantly, as they usually do not write any or few profits. Reason enough to take a closer look at two of the best-known German substance companies and ask whether there are also growth stocks with substance.

time to read: 3 minutes | Author: Nico Popp
ISIN: BAYER AG NA O.N. | DE000BAY0017 , MAS Gold Corp. | CA57457A1057 , BASF SE NA O.N. | DE000BASF111

Table of contents:


    Ryan Jackson, CEO, Newlox Gold Ventures Corp.
    "[...] We quickly learned that the tailings are high-grade, often as high as 20 grams of gold per tonne; because they are produced by artisanal miners, local miners who use outdated technology for gold production. [...]" Ryan Jackson, CEO, Newlox Gold Ventures Corp.

    Full interview

     

    Bayer: Population growth as a trump card

    Bayer, the chemical company from the Rhineland, has been considered an insider tip for some time. Since the Monsanto takeover and the glyphosate scandal, the Company has been a thorn in the side of some observers. Still, the Leverkusen-based Company is secretly and quietly working on the future. This work includes highly potent seeds and new collaborations in the biotech sector. Most recently, Bayer entered into a cooperation with a company from the cannabis sector. In general, Bayer exudes a great deal of imagination despite being a substance stock.

    The agrochemicals sector plays a central role in this. Since plant-based nutrition appears to be in demand with a view to the future and is also quite en vogue from a sustainability point of view, Bayer is well positioned with its division, which, after all, accounts for around 45% of sales. A growing world population will also ensure good sales at Bayer. Added to this is a handsome dividend. Bayer may not be a high-flyer, but it has what many investors are looking for right now: substance.

    MAS Gold: Great progress, hardly noticed

    One Company that must be considered a growth company when looking at its small market capitalization is MAS Gold. The gold company from Canada has continuously expanded its land rights and made strategic acquisitions in recent months. MAS Gold operates in the eastern part of the Canadian district of Saskatchewan, which is considered a typical mining region and offers companies optimal conditions, especially in the early stages. Along the historic La Ronge and Kisseynew Domain gold belts, MAS Gold now owns 33,843 hectares of land. MAS Gold is thus implementing the hub-and-spoke model it has always pursued, whereby several smaller properties are to be exploited with the help of central processing facilities. However, MAS Gold is also making progress operationally. Greywacke North reports 101,000 ounces of gold indicated and 55,000 ounces inferred since December last year. The Company is currently completing economic feasibility analyses for several properties and announced additional drill programs and a summary resource estimate before the end of the first quarter of 2022.

    The concept of MAS Gold ensures a continuous news flow, which has already been reflected in rising share prices in recent trading weeks. Although the Company with a market capitalization of less than EUR 12 million must be considered a speculative growth stock, the latest corporate news increasingly completes the picture of a successfully implemented growth strategy. As several small projects are often not adequately perceived by the market, the summary resource estimate announced by the Company in its current presentation for the first quarter of 2022 could shed more light and convince investors. As gold gains attractiveness, especially in crisis-ridden market phases, investors should not ignore this growth stock with substance.

    BASF is stepping on the gas! But what is the market doing?

    Much more boring than MAS Gold might be the share of BASF. Nevertheless, the Ludwigshafen-based Company, with operations in 80 countries worldwide, is considered a promising substance stock. Agricultural chemicals are also doing well here. BASF offers basic chemicals, industrial products and even products related to nutrition and care. In the first nine months of the fiscal year, the Palatinate-based Company increased its sales by 36% to a whopping EUR 58.5 billion. Profits also rose by more than 160%. Therefore, it is no wonder that BASF, with a current dividend yield of 5.7%, is extremely well received by the market. The recent dip in the share price should not shock investors. However, it shows that even a value stock like BASF cannot detach itself from the market as a whole.


    Even in difficult market phases, there are shares with potential. Substantial stocks offer dividends and a crisis-proof business. But growth stocks that implement a unique strategy and have been insufficiently perceived by the market so far can also decouple themselves from the general stock market sentiment. It remains to be seen whether MAS Gold will succeed, but the constellation around several smaller projects, a joint resource estimate and data on the economic feasibility in the coming months gives hope.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


    Der Autor

    Nico Popp

    At home in Southern Germany, the passionate stock exchange expert has been accompanying the capital markets for about twenty years. With a soft spot for smaller companies, he is constantly on the lookout for exciting investment stories.

    About the author



    Related comments:

    Commented by Stefan Feulner on May 19th, 2022 | 14:01 CEST

    Barrick Gold, MAS Gold, Deutsche Bank - Patience leads to wealth

    • Gold

    While the German benchmark index DAX continues to struggle with the psychologically important mark at 14,000 points, gold regained the USD 1.800 mark. The general conditions for investment are golden, but the price could again lose ground in the short term. Anticyclically, this creates almost historic buying opportunities. Be on the lookout.

    Read

    Commented by Armin Schulz on May 19th, 2022 | 12:10 CEST

    Barrick Gold, Barsele Minerals, Newmont - Gold stocks are under pressure

    • Gold

    With the start of the Ukraine crisis, the gold price rallied and came close to all-time highs. However, gold was then subsequently sold off again. The reason could be that the Russian currency is backed by gold. If one wants to sanction Russia, one must care for a falling gold price. If Russia lacks money, it would have to sell its gold, which would also put pressure on the gold price. The second theory is contradicted by the fact that the Russian central bank continued to buy gold at the end of March, albeit below the market price. The situation on the gold market should relax when the Ukraine conflict ends. Therefore, it is now time to look for the right gold company.

    Read

    Commented by Juliane Zielonka on May 19th, 2022 | 11:14 CEST

    Amazon, Edgemont Gold, Valneva - The real gold wins

    • Gold
    • Inflation
    • Biotech

    Only 'cash is king' seems to be the motto of this stock market week. High inflation is bringing tech stocks to their knees, and heavy artillery is also being brought to bear on Valneva's dead vaccine development front. The EU Commission wants to cancel the preliminary contract if the vaccine is not finally delivered within a month. Depth is also to be expected at Edgemont Gold, only this time, good things are hidden there. The gold exploration company is getting promising results from its third drill hole.

    Read